Autofluorescence imaging during thyroid cancer surgery to prevent low parathyroid function
Tests autofluorescence imaging during thyroid cancer surgery in adults to reduce low parathyroid function.
Plain-language title generated from the registry record
Registry title: Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism
Key facts
- Where
- Aarhus, DenmarkSee the site
Where in Denmark
- Aarhus University HospitalAarhus, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Aarhus University Hospital
- Trial code
- NCT06222606
- Record updated
- 6 October 2025
- Original description
The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).Read full original descriptionShow less
Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism - a Randomized, Controlled Trial
The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).
Inclusion: Age>18 years and able to give informed consent; Suspicion or diagnosis of thyroid cancer; Planned total thyroidectomy or completion thyroidectomy; Normocalcemia prior to surgery.
Exclusion: Planned simultaneous parathyroid surgery; Treatment with active vitamin D analogues; eGFR < 30.